Emerald Mutual Fund Advisers Trust’s Assembly Biosciences ASMB Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,385	Closed	-$5.01M	–	239
2020 Q3	$5.01M	Sell	25,385 -3,304	-12%	-$832K	0.22%	104
2020 Q2	$8.03M	Buy	28,689 +1,839	+7%	+$429K	0.38%	94
2020 Q1	$4.78M	Buy	26,850 +13,405	+100%	+$2.87M	0.3%	102
2019 Q4	$3.3M	Sell	13,445 -20,950	-61%	-$3.86M	0.13%	155
2019 Q3	$4.06M	Sell	34,395 -450	-1%	-$68.1K	0.18%	141
2019 Q2	$5.64M	Hold	34,845	–	–	0.22%	130
2019 Q1	$8.23M	Buy	34,845 +4,102	+13%	+$1.04M	0.33%	110
2018 Q4	$8.34M	Hold	30,743	–	–	0.39%	92
2018 Q3	$13.7M	Buy	30,743 +13,818	+82%	+$6.47M	0.46%	86
2018 Q2	$7.96M	Buy	16,925 +7,696	+83%	+$4.07M	0.29%	130
2018 Q1	$5.44M	Sell	9,229 -3,586	-28%	-$2.22M	0.21%	153
2017 Q4	$6.96M	Buy	+12,815	New	+$5.8M	0.28%	124

Other funds holding ASMB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ASMB Position: Q4 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 25,385 shares — an estimated $5.01M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ASMB in Q4 2017 and held it in 12 quarters. The position peaked at $13.7M in Q3 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

Emerald Mutual Fund Advisers Trust reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 25,385 Assembly Biosciences shares in Q4 2020, an estimated $5.01M.
Emerald Mutual Fund Advisers Trust first reported a position in Assembly Biosciences in Q4 2017 and held it in 12 quarters.
Emerald Mutual Fund Advisers Trust's Assembly Biosciences position peaked at $13.7M in Q3 2018.
109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.